← Open Payments lookup

IVROSE JANVIER: Open Payments

NPI 1821134453 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,106 in 32 payments from 15 companies in 2025. Trend: 2023 $663 · 2024 $1,188 · 2025 $1,106

Food & beverage: $1,106
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.1$121
ABIOMED1$118
MEDICOMP INC3$117
Esperion Therapeutics, Inc.4$97
Merck Sharp & Dohme LLC5$91
BIOTRONIK INC.1$89
Novartis Pharmaceuticals Corporation3$83
Abbott Laboratories1$81
Novo Nordisk Inc3$74
BridgeBio Pharma, Inc.3$71

Products named: TELEPATCH CARDIAC MONITOR, NEXLETOL, VERQUVO, BIOMONITOR, LEQVIO, CARDIOMEMS, Ozempic, Attruby.

Industry payments across NY — which companies pay providers there.